Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline.
McMullin MF, Harrison CN, Ali S, Cargo C, Chen F, Ewing J, Garg M, Godfrey A, S SK, McLornan DP, Nangalia J, Sekhar M, Wadelin F, Mead AJ; BSH Committee. McMullin MF, et al. Among authors: harrison cn. Br J Haematol. 2019 Jan;184(2):176-191. doi: 10.1111/bjh.15648. Epub 2018 Nov 27. Br J Haematol. 2019. PMID: 30478826 Free article. Review. No abstract available.
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
Campbell PJ, Scott LM, Buck G, Wheatley K, East CL, Marsden JT, Duffy A, Boyd EM, Bench AJ, Scott MA, Vassiliou GS, Milligan DW, Smith SR, Erber WN, Bareford D, Wilkins BS, Reilly JT, Harrison CN, Green AR; United Kingdom Myeloproliferative Disorders Study Group; Medical Research Council Adult Leukaemia Working Party; Australasian Leukaemia and Lymphoma Group. Campbell PJ, et al. Among authors: harrison cn. Lancet. 2005 Dec 3;366(9501):1945-53. doi: 10.1016/S0140-6736(05)67785-9. Lancet. 2005. PMID: 16325696 Clinical Trial.
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.
Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR, Futreal PA, Erber WN, McMullin MF, Harrison CN, Warren AJ, Gilliland DG, Lodish HF, Green AR. Scott LM, et al. Among authors: harrison cn. N Engl J Med. 2007 Feb 1;356(5):459-68. doi: 10.1056/NEJMoa065202. N Engl J Med. 2007. PMID: 17267906 Free PMC article.
Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis.
McMullin MF, Reilly JT, Campbell P, Bareford D, Green AR, Harrison CN, Conneally E; National Cancer Research Institute, Myeloproliferative Disorder Subgroup; Ryan K; British Committee for Standards in Haematology. McMullin MF, et al. Among authors: harrison cn. Br J Haematol. 2007 Sep;138(6):821-2. doi: 10.1111/j.1365-2141.2007.06741.x. Epub 2007 Aug 2. Br J Haematol. 2007. PMID: 17672880 Free article. No abstract available.
Low-dose thalidomide in myelofibrosis.
Weinkove R, Reilly JT, McMullin MF, Curtin NJ, Radia D, Harrison CN. Weinkove R, et al. Among authors: harrison cn. Haematologica. 2008 Jul;93(7):1100-1. doi: 10.3324/haematol.12416. Epub 2008 May 27. Haematologica. 2008. PMID: 18508796 Free article. Clinical Trial. No abstract available.
220 results